You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 021642

✉ Email this page to a colleague

« Back to Dashboard

NDA 021642 describes NASCOBAL, which is a drug marketed by Endo Operations and is included in two NDAs. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NASCOBAL profile page.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Summary for 021642

Tradename:	NASCOBAL
Applicant:	Endo Operations
Ingredient:	cyanocobalamin
Patents:	6

Pharmacology for NDA: 021642

Suppliers and Packaging for NDA: 021642

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642	NDA	ENDO USA, Inc.	49884-270	49884-270-82	4 SPRAY in 1 CARTON (49884-270-82)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SPRAY, METERED;NASAL			Strength	0.5MG/SPRAY
Approval Date:	Jan 31, 2005	TE:		RLD:	Yes
Patent:	⤷ Subscribe	Patent Expiration:	Aug 1, 2024	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	NASAL ADMINISTRATION OF CYANOCOBALAMIN
Patent:	⤷ Subscribe	Patent Expiration:	Mar 12, 2024	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	⤷ Subscribe	Patent Expiration:	Aug 1, 2024	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION

Expired US Patents for NDA 021642

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.